Expression of glutamine metabolism-related proteins in thyroid cancer

Hye Min Kim; Yu Kyung Lee; Ja Seung Koo

doi:10.18632/oncotarget.10682

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Expression of glutamine metabolism-related proteins in thyroid cancer

Hye Min Kim, Yu Kyung Lee and Ja Seung Koo _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:53628-53641. https://doi.org/10.18632/oncotarget.10682

Metrics: PDF 2271 views | HTML 2908 views | ?

Abstract

Hye Min Kim1, Yu Kyung Lee1, Ja Seung Koo1

1Department of Pathology, Yonsei University College of Medicine, Seoul, South Korea

Correspondence to:

Ja Seung Koo, email: [email protected]

Keywords: thyroid cancer, glutamine, metabolism, stroma, pathology

Received: February 01, 2016 Accepted: July 09, 2016 Published: July 18, 2016

ABSTRACT

Purpose: This study aimed to investigate the expression of glutamine metabolism-related protein in tumor and stromal compartments among the histologic subtypes of thyroid cancer.

Results: GLS1 and GDH expression in tumor and stromal compartments were the highest in AC than in other subtypes. Tumoral ASCT2 expression was higher in MC but lower in FC (p < 0.001). In PTC, tumoral GLS1 and tumoral GDH expression was higher in the conventional type than in the follicular variant (p = 0.043 and 0.001, respectively), and in PTC with BRAF V600E mutation than in PTC without BRAF V600E mutation (p<0.001). Stromal GDH positivity was the independent factor associated with short overall survival (hazard ratio: 21.48, 95% confidence interval: 2.178-211.8, p = 0.009).

Methods: We performed tissue microarrays with 557 thyroid cancer cases (papillary thyroid carcinoma [PTC]: 344, follicular carcinoma [FC]: 112, medullary carcinoma [MC]: 70, poorly differentiated carcinoma [PDC]: 23, and anaplastic carcinoma [AC]: 8) and 152 follicular adenoma (FA) cases. We performed immunohistochemical staining of glutaminolysis-related proteins (glutaminase 1 [GLS1], glutamate dehydrogenase [GDH], and amino acid transporter-2 [ASCT-2]).

Conclusion: Glutamine metabolism-related protein expression differed among the histologic subtypes of thyroid cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 10682

Publication Alerts

Post-Publication Promotion

Research Papers:

Expression of glutamine metabolism-related proteins in thyroid cancer

Abstract